C92.2
Clinical Information
-
A myelodysplastic/myeloproliferative disease characterized by the principal involvement of the neutrophil series with leukocytosis and multilineage dysplasia. The neoplastic cells do not have a philadelphia chromosome or the bcr/abl fusion gene. The prognosis is usually poor. who, 2001)
-
A myelodysplastic/myeloproliferative disorder characterized by myelodysplasia associated with bone marrow and peripheral blood patterns similar to chronic myeloid leukemia, but cytogenetically lacking a philadelphia chromosome or bcr/abl fusion gene genes, abl).
-
A myelodysplastic/myeloproliferative neoplasm characterized by the principal involvement of the neutrophil series with leukocytosis and multilineage dysplasia. The neoplastic cells do not have a philadelphia chromosome or the bcr/abl fusion gene. The prognosis is usually poor. who, 2001)
Details
-
C92.2 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
-
The 2023 edition of ICD-10-CM C92.2 became effective on October 1, 2022.
-
This is the American ICD-10-CM version of C92.2 – other international versions of ICD-10 C92.2 may differ.